Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post‐marketing safety

Documenti analoghi

• Food–drug interactions risk management: An emergent piece of pharmacovigilance systems
  di: Ana Margarida Advinha, et al.
  Pubblicazione: (2024)
• Phenotype versus genotype to optimize cancer dosing in the clinical setting—focus on 5‐fluorouracil and tyrosine kinase inhibitors
  di: Jennifer H. Martin, et al.
  Pubblicazione: (2024)
• Evaluation and optimization of sample size of neonates and infants for pediatric clinical studies on cefiderocol using a model‐based approach
  di: Daichi Yamaguchi, et al.
  Pubblicazione: (2024)
• Closing the Numeracy Gap in Medication Safety: Impact of a safeMedicate Intervention in Undergraduate Medical Education
  di: Soban Sadiq, et al.
  Pubblicazione: (2025)
• Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function
  di: Wei Yin, et al.
  Pubblicazione: (2024)